文献速递关节外科

髓芯减压联合BMAC与PRP治疗激素性股骨头坏死:至少10年随访

Hip Decompression Augmented With Bone Marrow Aspirate Concentrate and Platelet-Rich Plasma for Corticosteroid-Induced Osteonecrosis of the Femoral Head: A Minimum 10-Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2026-08-01

该研究对21例(34髋)激素性股骨头坏死(塌陷前)患者行髓芯减压联合骨髓浓缩物(BMAC)与富血小板血浆(PRP)治疗,平均随访11年。免于全髋关节置换(THA)生存率为62%,低Kerboul角(1-2级)患者免于塌陷生存率91%,高Kerboul角(3-4级)患者仅40%。高Kerboul角是塌陷的独立危险因素(HR 13.2,P=0.005)。

要点

  • 激素性股骨头坏死塌陷前行髓芯减压联合BMAC与PRP,10年免于THA生存率62%。
  • 术前Kerboul角1-2级者11年免于塌陷生存率91%,3-4级者仅40%。
  • 高Kerboul角独立增加塌陷风险(HR 13.2,P=0.005)。

核心结论

  • 至少10年随访显示,髓芯减压联合BMAC与PRP治疗激素性股骨头坏死可获得持续的保髋效果。
  • 病变大小(以Kerboul角定义)是长期成功的最重要预测因素。

研究设计与样本

  • 前瞻性队列研究(既往已发表队列的至少10年随访),纳入21例(34髋)塌陷前激素性股骨头坏死患者。
  • 手术时平均年龄43岁(范围22-66),平均体重指数31(范围22-41)。
  • 采用Kaplan-Meier分析评估免于股骨头塌陷和免于转为全髋关节置换(THA)的生存率,Cox回归分析失败危险因素,Harris髋关节评分评估功能。

主要发现

  • 平均随访11年(范围10-13年),免于转为THA的生存率为62%。
  • 转为THA的原因包括股骨头塌陷(n=5)、持续疼痛无塌陷(n=5)、骨关节炎进展(n=2)。
  • 术前低Kerboul角(1-2级)患者11年免于塌陷生存率91%、免于THA生存率66%;高Kerboul角(3-4级)患者两者均为40%(P=0.0004和P=0.083)。
  • 高术前Kerboul角独立增加股骨头塌陷风险(风险比13.2;P=0.005)。
  • 未转为THA的髋关节Harris髋关节评分从术前平均58改善至末次随访86(P<0.0001)。

关键数值与推荐

  • 术前Kerboul角1-2级者11年免于塌陷生存率91%,免于THA生存率66%。
  • 术前Kerboul角3-4级者11年免于塌陷和免于THA生存率均为40%。
  • 高Kerboul角与塌陷风险相关(HR 13.2;P=0.005)。

临床怎么用

  • 对于塌陷前激素性股骨头坏死,髓芯减压联合BMAC与PRP可作为保髋选项,长期效果与病变大小密切相关。
  • 术前应评估Kerboul角,低级别(1-2级)患者可能获得更优的长期保髋效果。

局限性

  • 样本量较小(21例患者、34髋)。
  • 为单队列前瞻性研究,无对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biologic augmentation with bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) has been used in conjunction with hip decompression (HD) for the treatment of pre-collapse osteonecrosis (ON) of the femoral head. This study reports a concise minimum 10-year follow-up of a previously published prospective cohort of patients who had corticosteroid-induced ON treated with HD augmented with BMAC and PRP. METHODS: There were 21 patients (34 hips) who had precollapse corticosteroid-associated ON who underwent HD combined with BMAC and PRP. Their mean age and body mass index at surgery were 43 years (range, 22 to 66) and 31 (range, 22 to 41), respectively. Survivorship free from femoral head collapse and conversion to total hip arthroplasty (THA) was assessed using Kaplan-Meier analysis. Risk factors for failure were evaluated using Cox regression analyses. Functional outcomes were assessed using the Harris Hip Score. RESULTS: At a mean follow-up of 11 years (range, 10 to 13), survivorship free from conversion to THA was 62%. Indications for conversion included femoral head collapse (n = 5), persistent pain without collapse (n = 5), and progression of osteoarthritis (n = 2). Patients who had low preoperative Kerboul angles (KAs) (grades 1 to 2) demonstrated 11-year survivorship of 91% free from collapse and 66% free from THA, whereas those who had high KA (grades 3 to 4) demonstrated survivorship of 40% for both outcomes (P = 0.0004 and P = 0.083, respectively). High preoperative KA independently increased the risk of femoral head collapse (hazard ratio 13.2; P = 0.005). In hips not converted to THA, mean Harris Hip Score improved from 58 preoperatively to 86 at final follow-up (P < 0.0001). There were no additional conversions to THA beyond the previously reported mean 7-year follow-up. CONCLUSIONS: At a minimum of 10 years, HD augmented with BMAC and PRP resulted in sustained hip preservation in patients who had corticosteroid-induced osteonecrosis. Lesion size, as defined by the KA, remains the most important predictor of longer-term success.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Restrepo DJ, Smith JH, Guarin Perez SF, et al. Hip Decompression Augmented With Bone Marrow Aspirate Concentrate and Platelet-Rich Plasma for Corticosteroid-Induced Osteonecrosis of the Femoral Head: A Minimum 10-Year Follow-Up. J Arthroplasty. 2026. PMID: 42542308. doi:10.1016/j.arth.2026.07.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。